Emergency Treatment With Nifekalant, a Novel Class III Anti-Arrhythmic Agent, for Life-Threatening Refractory Ventricular Tachyarrhythmias Post-Marketing Special Investigation-Reference-Cited by-同舟云学术

Emergency Treatment With Nifekalant, a Novel Class III Anti-Arrhythmic Agent, for Life-Threatening Refractory Ventricular Tachyarrhythmias Post-Marketing Special Investigation

Published:2005 Issue:10 Volume:69 Page:1237-1243
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Katoh Takao¹,Mitamura Hideo²,Matsuda Naoki³,Takano Teruo¹,Ogawa Satoshi⁴,Kasanuki Hiroshi³

Affiliation:

1. The First Department of Internal Medicine, Nippon Medical School

2. Saiseikai Chuo Hospital

3. Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University

4. Cardiopulmonary Division, Department of Medicine, Keio University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/69/10/69_10_1237/_pdf

Reference13 articles.

1. MS-551 Protects Against Ventricular Fibrillation in a Chronic Canine Model of Sudden Cardiac Death

2. MS-551: Pharmacological profile of a novel class III antiarrhythmic agent

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic/pharmacodynamic modeling of nifekalant injection with varies dosing plan in Chinese volunteers: a randomized, blind, placebo-controlled study;Journal of Pharmacokinetics and Pharmacodynamics;2023-08-11

2. Population Pharmacokinetic/Pharmacodynamic Modeling of Nifekalant Injection with varies dosing plan in Chinese Volunteers: A Randomized, Blind, Placebo-Controlled Study;2023-06-29

3. Ventricular fibrillation during pulmonary artery catheter placement in a patient with Stanford type A aortic dissection: a case report;AME Medical Journal;2023-03

4. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Circulation Journal;2022-10-25

5. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Journal of Arrhythmia;2022-10-25